Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 8 von 149
The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2334791-2334791
2024

Details

Autor(en) / Beteiligte
Titel
Successful treatment of recalcitrant generalized pustular psoriasis of pregnancy with spesolimab
Ist Teil von
  • The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2334791-2334791
Ort / Verlag
England: Taylor & Francis Group
Erscheinungsjahr
2024
Link zum Volltext
Quelle
Taylor & Francis Journals Auto-Holdings Collection
Beschreibungen/Notizen
  • Generalized pustular psoriasis (GPP) in pregnancy can lead to severe complications for both mother and fetus. The treatment of this disease is challenging, especially in recalcitrant and severe cases. Until present, there are no evidence-based guidelines for the treatment of GPP in pregnancy. Spesolimab, a human monoclonal antibody against the IL-36 receptor, has recently attracted attention as a new therapy for GPP flare. This biologic provides rapid and sustained control of symptoms of GPP flare, although its use in pregnant women has not been reported to date. Here, we report a pregnant woman with refractory GPP who did not respond well to systemic steroids. Administration of spesolimab resulted in complete control of the disease and the birth of a healthy baby. Our case demonstrates that IL-36RN inhibitors are a potentially effective and safe treatment option for GPP in pregnancy.
Sprache
Englisch
Identifikatoren
ISSN: 0954-6634
eISSN: 1471-1753
DOI: 10.1080/09546634.2024.2334791
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_ce61424594914b42b0372e90403c9133

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX